We are live on ! Find out more
LD

Lipe & Dalton Portfolio holdings

AUM $215M
1-Year Est. Return 39.53%
This Fund
S&P 500
This Quarter Est. Return
+4.88%
1 Year Est. Return
+39.53%
3 Year Est. Return
+89.64%
5 Year Est. Return
+111.74%
10 Year Est. Return
+427.59%
AUM
$176M
AUM Growth
+$942K
Cap. Flow
-$5.49M
Cap. Flow %
-3.13%
Top 10 Hldgs %
38.89%
Holding
105
New
3
Increased
10
Reduced
53
Closed
3

Top Buys

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$1.13M
2
CVS icon
CVS Health
CVS
+$887K
3
SCHW
Charles Schwab
SCHW
+$199K
4
ADBE icon
Adobe
ADBE
+$161K
5
QCOM icon
Qualcomm
QCOM
+$139K

Top Sells

Rank Stock Value
1
BKNG icon
Booking.com
BKNG
+$2.79M
2
ABBV icon
AbbVie
ABBV
+$1.84M
3
DE icon
Deere & Co
DE
+$606K
4
AAPL icon
Apple
AAPL
+$291K
5
T icon
AT&T
T
+$286K

Sector Composition

Rank Sector Weight
1 Technology 22.66%
2 Industrials 17.81%
3 Healthcare 17.37%
4 Financials 14.7%
5 Consumer Staples 7.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MS icon
26
Morgan Stanley
MS
$337B
$2.33M 1.33%
27,261
-823
-3% -$70.4K
LMT icon
27
Lockheed Martin
LMT
$134B
$2.25M 1.28%
4,895
-120
-2% -$55.7K
MLM icon
28
Martin Marietta Materials
MLM
$33.6B
$2.23M 1.27%
4,825
-250
-5% -$98.6K
V icon
29
Visa
V
$677B
$2.19M 1.25%
9,203
-150
-2% -$34.3K
AMGN icon
30
Amgen
AMGN
$203B
$2.09M 1.19%
9,426
-205
-2% -$47.6K
SYF icon
31
Synchrony
SYF
$23.7B
$1.94M 1.1%
57,047
-1,070
-2% -$32.7K
CVS icon
32
CVS Health
CVS
$137B
$1.92M 1.09%
27,745
+12,471
+82% +$887K
VRTX icon
33
Vertex Pharmaceuticals
VRTX
$121B
$1.77M 1.01%
5,035
-50
-1% -$16.8K
TRP icon
34
TC Energy
TRP
$73.5B
$1.75M 1%
43,347
-240
-0.6% -$9.8K
MRNA icon
35
Moderna
MRNA
$21.5B
$1.75M 0.99%
14,362
-5
-0% -$667
CI icon
36
Cigna
CI
$76.6B
$1.71M 0.98%
6,108
– –
BAM icon
37
Brookfield Asset Management
BAM
$74B
$1.66M 0.95%
50,992
-948
-2% -$30.5K
J icon
38
Jacobs Solutions
J
$15.9B
$1.47M 0.84%
14,942
-973
-6% -$92.8K
HSY icon
39
Hershey
HSY
$35.4B
$1.4M 0.79%
5,586
-99
-2% -$26K
AMZN icon
40
Amazon
AMZN
$2.5T
$1.39M 0.79%
10,625
-175
-2% -$20K
MRK icon
41
Merck
MRK
$324B
$1.36M 0.78%
11,822
+1
+0% +$114
STZ icon
42
Constellation Brands
STZ
$22.2B
$1.35M 0.77%
5,482
-24
-0.4% -$5.62K
QCOM icon
43
Qualcomm
QCOM
$176B
$1.32M 0.75%
11,125
+1,205
+12% +$139K
COO icon
44
Cooper Companies
COO
$13.7B
$1.28M 0.73%
13,320
-100
-0.7% -$9.38K
JNJ icon
45
Johnson & Johnson
JNJ
$635B
$1.23M 0.7%
7,441
+291
+4% +$47K
KVUE icon
46
Kenvue
KVUE
$37B
$1.15M 0.65%
+43,400
New +$1.13M
DENN
47
DELISTED
Denny's
DENN
$1.14M 0.65%
92,136
+1,000
+1% +$11.4K
MDT icon
48
Medtronic
MDT
$107B
$1.13M 0.65%
12,859
+827
+7% +$71.2K
ORCL icon
49
Oracle
ORCL
$331B
$1.08M 0.62%
9,081
-504
-5% -$52.1K
PRU icon
50
Prudential Financial
PRU
$41.7B
$1.04M 0.6%
11,848
-247
-2% -$20.7K
1
2
3 4 5

Similar funds

VEA
Virtus ETF Advisers New York $215M AUM 53.68% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return

Lipe & Dalton's Q2 2023 Portfolio in Review

As of Q2 2023, Lipe & Dalton held 105 positions worth $176M, up 0.54% from $175M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Lipe & Dalton withdrew a net $5.49M in Q2 2023, closing 3 positions and reducing 53 holdings. Its most notable exit was Booking.com, an estimated $2.79M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Lipe & Dalton opened a new position in Kenvue worth $1.15M.

  • Lipe & Dalton's largest Q2 2023 buy was Kenvue: 43,400 shares worth $1.15M.
  • Lipe & Dalton added most to CVS Health in Q2 2023, an estimated $887K increase.
  • Lipe & Dalton's biggest Q2 2023 reduction was AbbVie, cutting an estimated $1.84M.
  • Lipe & Dalton fully exited Booking.com in Q2 2023, selling an estimated $2.79M.
  • Lipe & Dalton's ten largest holdings make up 39% of its $176M portfolio in Q2 2023.
  • Lipe & Dalton opened 3 new positions and closed 3 in Q2 2023.
  • Lipe & Dalton's portfolio value rose 0.54% quarter-over-quarter to $176M.

Based on Lipe & Dalton's 13F filing for Q2 2023, filed 26 Jul 2023.